Part Number
Part Number:
NSN:
NIIN:
Item Name:
POTASSIUM CHLORIDE EXTENDED-RELE
Definition:
CAGE Information
| Code | Company |
|---|---|
| 1F095 | SCHERING-PLOUGH CORPORATION |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG |
| THPE | THERAPEUTIC EQUIVALENT | K-DUR BY KEY PHARMACEUTICALS |
| CBBL | FEATURES PROVIDED | UNIT DOSE |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEAT | SPECIAL FEATURES | 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS |